ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 627669 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 627669; 2) Community: the network communities that were significantly associated with the response to NSC 627669; 3) Molecule: the relationships between components within communities and NSC 627669; 4) MDR: the compounds that were significantly associated with the NSC 627669.

NSC Compound Enrichment Correlation
NSC 758359 N3-[1-(3-phenoxybenzyl)-1H-1,2,3-triazol-4-yl]methyl-2-(4-fluoroanilino)nicotinamide 0.0133299224082802 -0.23283928
NSC 76150 Null 0.0133299224082802 0.42193111
NSC 104801 Cytembena 0.0133299224082803 0.24749814
NSC 133118 2H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, 2-.beta.-D-ribofuranosyl- (9CI) 0.0133299224082803 0.11742756
NSC 144163 Quinoxaline, 6-chloro-2,3-bis(iodomethyl)- 0.0133299224082803 0.28019323
NSC 164970 Propanedinitrile, [(3,5-dibromo-2-ethoxyphenyl)methylene]- 0.0133299224082803 0.30751558
NSC 166199 Phosphinic amide, P,P-bis(1-aziridinyl)-N-tricyclo[3.3.1.1(3.7)]dec-1-yl- (9CI) 0.0133299224082803 0.31334372
NSC 616960 2[5H]-Furanone, 5-[(.beta.-D-glucopyranosyloxy)methyl]-,(S)- (9CI) 0.0133299224082803 0.19668643
NSC 624191 Null 0.0133299224082803 0.40096843
NSC 363787 Kaur-16-en-15-one,1,3,7,11-tetrakis(acetyloxy)-12-hydroxy-, (1.alpha.,3.beta.,7.beta.,11.beta.,12.alpha.)- 0.0139796580235792 0.28723821
Total:87  Current:32    [First] [Prev] [Next] [Last]